MED19 antibody (AA 51-150) (Biotin)

Catalog No. ABIN6982694

The Rabbit Polyclonal anti-MED19 antibody has been validated for ELISA, IHC (fro) and IHC (p). It is suitable to detect MED19 in samples from Rat.

Quick Overview for MED19 antibody (AA 51-150) (Biotin) (ABIN6982694)

Target: MED19 (Mediator Complex Subunit 19 (MED19))

Reactivity: Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This MED19 antibody is conjugated to Biotin

Application: ELISA, Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Product Details anti-MED19 Antibody (Biotin)

Binding Specificity: AA 51-150

Cross-Reactivity: Rat

Predicted Reactivity: Human,Mouse,Cow,Horse,Chicken

Purification: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human MED19/LCMR1

Isotype: IgG

Application Details

Application Notes: IHC-P 1:200-400
IHC-F 1:100-500

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Preservative: ProClin

Precaution of Use: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Store at -20°C for 12 months.

Expiry Date: 12 months

Target Details for MED19

Target: MED19 (Mediator Complex Subunit 19 (MED19))

Alternative Name: MED19

Background:

Synonyms: LCMR1, Lung cancer metastasis related protein 1, Lung cancer metastasis-related protein 1, med19, MED19_HUMAN, Mediator complex subunit 19, Mediator of RNA polymerase II transcription subunit 19, Mediator of RNA polymerase II transcription, subunit 19 homolog.

Background: MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]

Gene ID: 219541

UniProt: A0JLT2

Pathways: Regulation of Lipid Metabolism by PPARalpha